Keira Havens, Jason Kakoyiannis, Mike Koeris & Ted Fjällman

The plan for responsible biological innovation sounds simple in theory: design thoughtfully, communicate effectively, listen carefully, and provide tangible benefits to all stakeholders. In practice, however, we have seen this process fail time and time again as companies, consumers, and advocacy groups talk at cross purposes.